Cardiology

Posted: Published on March 31st, 2016

This post was added by Dr P. Richardson

Adult Congenital Heart Disease Clinical Care Evaluation

Utilization and Perception of Care by Physician Extenders in the Adult Congenital Heart Disease Program

Covered Cheatham Platinum CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated with Coarctation of the Aorta (COAST II) Continued Study Access

Coarctation of the Aorta Stent Trial (COAST) Continued Study Access

Trial of Beta Blocker Therapy vs Angiotensin II Receptor Blocker Therapy in Individuals with Marfan Syndrome

Comparison between Surgical vs. Balloon Angioplasty vs. Intravascular Stent Placement for Recurrent or Native Coarctation of the Aorta

Coping Mechanisms, Gender Difference, and Cardiovascular Risk in Adolescents and Adults with Congenital Heart Disease

Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Do Serum Biochemical and Hematopoietic, or Stool Biomarkers Predict Low Cardiac Index in Patients with Fontan Physiology?

Alloantibodies: Prevalence and Impact in Pediatric Heart Transplantation

Alloantibodies in Pediatric Heart Transplantation

MRI Quantification of Cardiac Fibrosis after Heart Transplantation

Female Sexual Dysfunction Among Adults with Complex Congenital Heart Disease

Dexmedetomidine vs. Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia

Transplant Epstein-Barr Virus (EBV) Disease Pathogenesis and Immunotherapy

Closure of Atrial Septal Defects with the Amplatzer Septal Occluder Post Market Study

Read more from the original source:
Cardiology

Related Posts
This entry was posted in Cardiology. Bookmark the permalink.

Comments are closed.